Sept. 3, 2010: update to Letter of Concern signers now at home page. Older home page archived.

Sept. 3, 2010: We ask for clarifications from OHRP and FDA.

Sept. 2, 2010: Responses from FDA and OHRP.

July 7, 2010: The Gay and Lesbian Medical Association (GLMA) and the National Center for Lesbian Rights (NCLR) issue a joint statement “urging investigation of alleged misuse of prenatal drug to manipulate sexual orientation.”

July 2, 2010: Newsweek covers controversy over prenatal dex for CAH

July 2, 2010: Los Angeles Times health blog on controversy over prenatal dex for CAH

June 29, 2010: Bioethics Forum publishes “Preventing Homosexuality (and Uppity Women) in the Womb?”, by Alice Dreger, Ellen K. Feder, and Anne Tamar-Mattis

June 28, 2010: Nature Medicine blog, “Clitoroplasty and Dex Studies Scrutinized by Bioethicists”

June 27, 2010: Advocates for Informed Choice publishes Statement about Recent Controversy About Genital Surgery and Dexamethasone

June 21, 2010: Endo Daily publicizes new draft clinical practice guidelines for the treatment of CAH, clarifying that prenatal dexamethasone for CAH is experimental

June 19, 2010: Time magazine reports mothers not appropriately informed before being administered prenatal dex for CAH; covers our calls for investigations

June 16, 2010: Bioethics Forum publishes “Bad Vibrations” by Alice Dreger and Ellen K. Feder

June 1, 2010: Endocrine Today publishes “Research Into Outcomes of Treatment for Children with Differences in Sex Development Demands Caution,” by Anne Tamar-Mattis

April 24, 2010: “First Weill Cornell CAH Conference” (cosponsored with the CARES Foundation): Janet Green (former CARES Board member) raises questions regarding claims about prenatal dex and the use of “clitoral vibratory testing” on girls

March 3, 2010: The federal Office for Human Research Protections responds, indicating they are investigating our concerns.

March 3, 2010: The Endocrine Society responds to our letter indicating they will not take action because they apparently don’t see the matter as their responsibility.

March 1, 2010: Endocrine Today publishes “Giving Pediatric Patients a Voice in Treatment of DSD,” by Anne Tamar-Mattis

Feb. 25, 2010: The Lawson Wilkins Pediatric Endocrine Society responds to our letter and seems to miss the point of our contacting them.

Feb. 23, 2010: The CARES Foundation answers our letter saying their board will discuss our concerns.

Feb. 22, 2010: Drs. Dreger and Feder send a letter to the CARES Foundation.

Feb. 22, 2010, Drs. Feder and Dreger send a letter to The Endocrine Society.

Feb. 22, 2010, Drs. Feder and Dreger send a letter to the Lawson Wilkins Pediatric Endocrine Society.

Feb. 22, 2010, Drs. Feder and Dreger send a letter to the Vice President of Research of Columbia University regarding the work on the prenatal dex population by Dr. Heino Meyer-Bahlburg.

Feb. 22, 2010, Drs. Feder and Dreger send follow-up letters to the FDA Office of Pediatric Therapeutics, Cornell-Weill Medical School, Mount Sinai School of Medicine, Florida International University, and the Office for Human Research Protections. Click here to read that.

Feb. 11, 2010: Eleven adult advocates who were themselves born with mixed markers of sex send their own letters of concern to the FDA, OHRP, Weill-Cornell, Mount Sinai, and Florida International.

Feb. 10, 2010: Advocates for Informed Choice submits their own letters of concern to the FDA, OHRP, Weill-Cornell, Mount Sinai, and Florida International University.

Feb. 8-9, 2010: We advise the CARES Foundation of our findings so far.

Feb. 8, 2010: The FDA confirms they are looking into our concerns.

Feb. 8, 2010: Bioethics Forum publishes post on fetal dex from Hilde Lindemann, Ellen Feder, and Alice Dreger. (See also video discussion with Hilde Lindemann)

Feb. 7, 2010: Florida International University confirms they are looking into our concerns.

Feb. 3, 2010: Advocates for Informed Choice issues a statement on the legal and ethical issues surrounding this use of fetal dexamethasone.

Feb. 3, 2010: Florida International University indicates they are looking into our concerns.

Feb. 2, 2010: Formal letters of concern are sent from 32 professional researchers in Bioethics and allied fields to the FDA, the OHRP, Weill-Cornell, Mount Sinai, and Florida International University

Jan. 31, 2010: New York Times reports on the FDA cracking down on doctors’ pitches for non-FDA-approved uses of drugs (like this in the case of fetal dex for CAH?)

Jan. 29, 2010: Janet Green, a mother with CAH, speaks out about her concerns about what’s happening to some pregnant women suspected of carrying a girl with CAH